Sernova Biotherapeutics Appoints John L. Brooks III as Chair of Board, Former Joslin Diabetes CEO to Lead Company in Advancing T1D Cure
I'm PortAI, I can summarize articles.
Sernova Biotherapeutics Inc. has appointed John L. Brooks III as the Chair of its Board of Directors. Brooks, a former CEO of Joslin Diabetes, brings extensive experience in type 1 diabetes and life sciences. He will lead the company in advancing its Cell Pouch Bio-hybrid Organ, aimed at providing a potential functional cure for type 1 diabetes.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments